Thermo Fisher Scientific, Inc. (NYSE:TMO) Q3 2019 Earnings Conference Call - Final Transcript

Oct 23, 2019 • 08:30 am ET

Previous

Thermo Fisher Scientific, Inc. (NYSE:TMO) Q3 2019 Earnings Conference Call - Final Transcript

Share
Close

Loading Event

Loading Transcript

Presentation
Operator
Operator

Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2019 Third Quarter Conference Call. [Operator Instructions]

I would now like to introduce our moderator for the call, Mr. Kenneth Apicerno, Vice President of Investor Relations. Mr. Apicerno, you may begin the call.

Executive
Kenneth J. Apicerno

Good morning, and thank you for joining us. On the call with me today is Marc Casper, our President and Chief Executive Officer; and Stephen Williamson, Senior Vice President and Chief Financial Officer.

Please note this call is being webcast live and will be archived on the Investors Section of our website thermofisher.com under the heading Webcasts and Presentations until November 8, 2019. A copy of the press release of our third quarter 2019 earnings and future expectations is available in the Investors Section of our website under the heading Financial Results.

So, before we begin, let me briefly cover our Safe Harbor statement. Various remarks that we may make about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the company's quarterly report on Form 10-Q for the quarter ended June 29, 2019 under the caption Risk Factors, which is on file with the Securities and Exchange Commission, and is also available in the Investor section of our website under the heading SEC filings.

While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so even if our estimates change. Therefore you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.

Also during this call, we'll be referring to certain financial measures not prepared in accordance with Generally Accepted Accounting Principles or GAAP. A reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures is available in the press release of our third quarter 2019 earnings and future expectations and also in the Investors section of our website under the heading Financial Information.

So with that, I'll now turn the call over to Marc.

Executive
Marc N. Casper

Thank you, Ken. Hello and good morning everyone. Thanks for joining us today for our Q3 call. We delivered another great quarter, achieving strong financial performance, while continuing to effectively execute our growth strategy to make Thermo Fisher Scientific an even stronger partner for our customers.

As you saw in our press release, we delivered excellent revenue and earnings growth. It was another active quarter for new product innovation and we expanded our global capabilities to enhance our unique customer value proposition. We also continue to execute our capital deployment strategy, completing strategic M&A to further strengthening our offering and returning capital to shareholders through stock buybacks and dividends.

We carried our strong growth momentum into Q3 by capitalizing on the continued strength of our end markets and